{"version":"1.0","provider_name":"Market Newsdesk","provider_url":"https:\/\/www.marketnewsdesk.com","author_name":"Newsdesk","author_url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/","title":"Nordic Nanovector ASA: Financial calendar - Market Newsdesk","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"rh8k4fDTZm\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nordic-nanovector-asa-financial-calendar\/\">Nordic Nanovector ASA: Financial calendar<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.marketnewsdesk.com\/index.php\/nordic-nanovector-asa-financial-calendar\/embed\/#?secret=rh8k4fDTZm\" width=\"600\" height=\"338\" title=\"&#8220;Nordic Nanovector ASA: Financial calendar&#8221; &#8212; Market Newsdesk\" data-secret=\"rh8k4fDTZm\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.marketnewsdesk.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"PR Newswire OSLO, Norway, March 12, 2021 \/PRNewswire\/ &#8212; FINANCIAL YEAR 2020 22.03.2021 &#8211; Extraordinary General Meeting 26.03.2021 &#8211; Annual Report FINANCIAL YEAR 2021 28.04.2021 &#8211; Annual General Meeting 26.05.2021 &#8211; Quarterly Report &#8211; Q1 27.08.2021 &#8211; Half-yearly Report 18.11.2021 &#8211; Quarterly Report &#8211; Q3 For further information, please contact:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 IR enquiries Malene Brondberg, CFOCell: +44 7561 431 762Email:\u00a0ir@nordicnanovector.com Media Enquiries Mark Swallow\/Frazer Hall\/David Dible (Citigate Dewe Rogerson)Tel: +44 203 926 8535Email:\u00a0nordicnanovector@citigatedewerogerson.com About Nordic Nanovector: Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care. The Company aspires to become a leader in the development of targeted therapies for haematological cancers. Nordic Nanovector&#8217;s lead clinical-stage candidate is Betalutin\u00ae, &hellip; Continue reading \"\"","thumbnail_url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO07951&amp;sd=2021-03-12"}